FDA Recalls IDArubicin Injection for Particulate Matter Contamination
Teva Pharmaceuticals is recalling IDArubicin Hydrochloride Injection vials due to the presence of silica and iron oxide particulate matter. The recall affects nationwide distribution within the United States.
- Product
- IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals, USA, Inc., North Wales, PA 19454, NDC 0703-4154-11.
- Category
- Drug
- Distribution
- Distributed nationwide